DTL
ITOS

Dynamic Technology Lab’s iTeos Therapeutics ITOS Stock Holding History

Dynamic Technology Lab’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-77,371
Closed -$771K – 1017
2025
Q2 		$771K Buy
77,371
+66,114
+587% +$533K 0.1% 351
2025
Q1 		$67K Buy
+11,257
New +$82.6K 0.01% 917
2024
Q1 		– Sell
-47,461
Closed -$520K – 1236
2023
Q4 		$520K Buy
47,461
+37,080
+357% +$368K 0.06% 574
2023
Q3 		$114K Sell
10,381
-260
-2% -$3.33K 0.01% 854
2023
Q2 		$141K Sell
10,641
-1,215
-10% -$17.3K 0.02% 872
2023
Q1 		$161K Buy
+11,856
New +$212K 0.01% 937
2022
Q3 		– Sell
-16,900
Closed -$348K – 1325
2022
Q2 		$348K Sell
16,900
-200
-1% -$4.75K 0.04% 714
2022
Q1 		$550K Buy
+17,100
New +$621K 0.06% 537

Other funds holding ITOS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Dynamic Technology Lab's ITOS Position: Q3 2025 in Review

Dynamic Technology Lab sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 77,371 shares — an estimated $771K sold.

Dynamic Technology Lab first reported a position in ITOS in Q1 2022 and held it in 8 quarters. The position peaked at $771K in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

  • Dynamic Technology Lab reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Dynamic Technology Lab sold 77,371 iTeos Therapeutics shares in Q3 2025, an estimated $771K.
  • Dynamic Technology Lab first reported a position in iTeos Therapeutics in Q1 2022 and held it in 8 quarters.
  • Dynamic Technology Lab's iTeos Therapeutics position peaked at $771K in Q2 2025.
  • 1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Dynamic Technology Lab's 13F filing for Q3 2025, filed 13 Nov 2025.